Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors

Who May Qualify: - For intervention phase: Individuals aged 20 years and above. For baseline and endline assessments (before and after the intervention): Individuals aged 30 years and above. - Participants residing in the randomized clusters of Kabul, Afghanistan Individuals willing to participate in the study and provide consent. - All individuals with normoglycemia, intermediate hyperglycaemia, and diabetes are encouraged to participate. - Participants who can attend the scheduled meetings and interventions as per the study protocol. Who Should NOT Join This Trial: - For Intervention phase: Individuals below the age of 20 years. For baseline and endline assessments (before and after the intervention): individuals below the age of 30 years. - Individuals unwilling to provide consent for participation. - Participants with reported health conditions that may hinder their active involvement in the study. - Individuals with non-compliance with research protocols Always talk to your doctor about whether this trial is right for you.